Module

Natural History of Chronic HBV Infection in Patients Receiving Anti-HBV Therapy

Source: Clinical Strategies for Preventing and Managing Resistance to Anti-HBV Agents

Natural History of Chronic HBV Infection in Patients Receiving Anti-HBV Therapy

Faculty:
George K. K. Lau, MD

CME CREDIT INFORMATION

Release Date: 04/14/06

Expiration Date: 04/13/07

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss the natural history of both treated and untreated chronic HBV infection
Review long-term outcomes of HBV treatment with nucleotide analogues or interferons
Compare and contrast various combinations of interferons and nucleotide analogues in the treatment of chronic hepatitis B

Topics covered include:

Natural History of Untreated Chronic HBV Infection
Natural History of Treated Chronic Hepatitis B Infection
Long-term Outcomes of Patients Treated With Nucleos(t)ide Analogues
Long-term Outcomes of Patients Treated With Nucleos(t)ide Analogues: Long-term adefovir studies
Long-term Outcomes of Patients Treated With Nucleos(t)ide Analogues: Long-term entecavir studies
Long-term Outcomes of Patients Treated With IFN
Combination Therapies
Conclusion

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.